背景:大多数美国人现在访问社交媒体平台,包括YouTube,获取健康信息。然而,很少有研究评估与阿片类药物使用障碍(OUD)相关的YouTube内容的质量,包括OUD(MOUD;丁丙诺啡)和减少伤害资源的药物(例如,纳洛酮)。这种横截面分析的目的是评估质量,准确度,MOUD的可靠性和YouTube上与减少伤害相关的视频内容。
方法:研究小组在2022年6月至2022年7月之间使用与MOUD和减少伤害内容相关的关键字进行了YouTube搜索(例如,\"Suboxone,\"\"美沙酮,\"\"Narcan\")。对每个搜索词中观看次数最多的5个视频进行了质量分析(即,全球质量量表;GQS),准确性(即,JAMA基准标准),和可靠性(即,DISCERN).非英语视频,重复,或者没有直接提到OUD,穆德,或损害减少被排除在审查之外(N=6)。
结果:YouTube视频(N=70)主要由医疗专业人员制作(27.1%),独立非医疗使用者(21.4%;例如,vlogger,个人记录他们的经历),医疗机构(17.1%;例如,医院,治疗方案),和/或培养基(14.3%;例如,新闻机构)。目标受众主要是公众(65.7%),使用阿片类药物的人(20.0%),和医疗保健提供者(10.0%)。包含MOUD内容的视频(N=64,61.4%)主要集中在suboxone(25.0%),美沙酮(23.4%),次级(14.1%),和舒布泰特/丁丙诺啡(14.1%)。基于GQS的中位数质量评分为2,其中3个视频获得最高质量评级(5)。根据所有三个JAMA基准标准,两个视频的准确性被高度评价。非医学教育频道制作的视频在DISCERN标准中总体可靠性得分最高(中位数为4),其次是医疗专业人员(中位数3),和医疗机构(中位数2.5)。
结论:总体质量,准确度,YouTube上发布的MOUD和减少伤害相关内容的可靠性较差。YouTube上缺乏基于证据的内容,这加强了公共卫生专家参与在社交媒体上传播基于指南的内容的必要性。
BACKGROUND: Most Americans now access social media platforms, including
YouTube, to obtain health information. However, few studies have evaluated the quality of
YouTube content related to opioid use disorder (OUD), including medications for OUD (MOUD; buprenorphine) and harm reduction resources (e.g., naloxone). The purpose of this cross-sectional analysis was to assess the quality, accuracy, and reliability of MOUD and harm reduction-related video content available on
YouTube.
METHODS: The study team conducted a
YouTube search between June 2022 and July 2022 using key words related to MOUD and harm reduction content (e.g., \"suboxone,\" \"methadone,\" \"Narcan\"). The 5 most viewed videos from each search term were analyzed for quality (i.e., Global Quality Scale; GQS), accuracy (i.e., JAMA Benchmark Criteria), and reliability (i.e., DISCERN). Videos that were non-English, duplicate, or that did not directly mention OUD, MOUD, or harm reduction were excluded from the review (N = 6).
RESULTS: YouTube videos (N = 70) were mostly produced by medical professionals (27.1 %), independent nonmedical users (21.4 %; e.g., vloggers, individuals documenting their experiences), medical organizations (17.1 %; e.g., hospitals, treatment programs), and/or media (14.3 %; e.g., news agencies). The target audience was primarily the general public (65.7 %), people who use opioids (20.0 %), and healthcare providers (10.0 %). Videos containing MOUD content (N = 64, 61.4 %) mostly focused on suboxone (25.0 %), methadone (23.4 %), Sublocade (14.1 %), and subutex/buprenorphine (14.1 %). The median quality score was 2 based on the GQS with 3 videos receiving the highest quality rating (5). Two videos were highly rated for accuracy per all three JAMA Benchmark criteria. Videos produced by nonmedical educational channels had the highest overall reliability scores on the DISCERN criteria (median 4), followed by medical professionals (median 3), and medical organizations (median 2.5).
CONCLUSIONS: The overall quality, accuracy, and reliability of MOUD and harm reduction related content posted on
YouTube is poor. The lack of evidence-based content posted on YouTube reinforces the need for public health expert involvement in disseminating guideline-based content on social media.